Safety and immunogenicity of Boostrix in adults aged 65 years and older
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

Safety and immunogenicity of Boostrix in adults aged 65 years and older

Filetype[PDF-731.45 KB]


  • English

  • Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov